In this supplement to EMJ Nephrology, two leading nephrologists, Patrice Ambühl and Jordi Bover, discussed the burden and management of secondary hyperparathyroidism (SHPT): a common complication in chronic kidney disease (CKD). In particular, they reflected on the challenges of treating SHPT in patients with non-dialysis CKD (ND-CKD).
EMJ Nephrology 9 [Supplement 1] . 2021
May 2021
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given